Business & regional news

Month Year

Month Year

May 2, 2022

Medtronic announces first enrollment in pivotal trial of patients with moderate, symptomatic aortic stenosis

EXPAND TAVR II Pivotal Trial evaluating the Evolut™ TAVR platform in a new patient population
- Structural Heart and Aortic
Apr 19, 2022

Medtronic Announces Collaboration with Cydar Medical to Bring Endovascular Aortic Care to a New Level with Cutting-Edge Artificial Intelligence Technology
- Structural Heart and Aortic
Apr 4, 2022

Medtronic TAVR platform first and only to demonstrate durability benefit over SAVR at 5 years

ACC.22: Late-breaking data show CoreValve™ and Evolut™ is the only platform to out-perform surgery in valve durability at five years
- Structural Heart and Aortic

Show per page